指南与共识重症综合管理与镇静镇痛消化、代谢与肾脏急症

危重症患者营养风险筛查推荐意见:一项元研究及临床指南质量评价

Nutritional Risk Screening Recommendations for Critically Ill Patients: A Meta-Research Study and Quality Appraisal of Clinical Guidelines.
指南 / 共识 · J Hum Nutr Diet · 2026-01-01
一句话结论纳入的4部指南方法学质量总体满意(AGREE II 范围与目的84.4%、表达清晰性92.0%),但适用性最低(50.0%),推荐可信度与证据质量存在重要局限。

该元研究系统检索2026年1月至4月Embase、PubMed、SciELO、Scopus、LILACS、Google Scholar及指南库,纳入4部包含危重症成人营养风险筛查推荐的临床实践指南、共识声明和立场文件。采用AGREE II和AGREE-REX评价指南质量,用ROBINS-E和AMSTAR 2评价支持推荐意见的原始研究和系统评价。AGREE II显示范围与目的84.4%、表达清晰性92.0%满意,适用性仅50.0%最低;AGREE-REX总体推荐质量中等(64.8%),中国重症医学会指南得分最高(77.8%)。支持推荐意见的原始研究多为高或很高偏倚风险,一项系统评价为极低置信度。

要点

  • 共纳入4部含危重症成人营养风险筛查推荐的指南,AGREE II总体方法学质量满意。
  • AGREE II各领域中范围与目的84.4%、表达清晰性92.0%表现较好,适用性50.0%最低。
  • AGREE-REX评价推荐质量总体中等(64.8%),中国重症医学会指南得分最高(77.8%)。
  • 支持筛查推荐意见的原始研究多被评定为高或很高偏倚风险,一项系统评价为极低置信度。
  • 作者认为未来指南制定需更高质量证据合成、透明偏倚风险评估和改进的实施策略。

适用人群与场景

  • 危重症成人患者,针对营养风险筛查推荐意见。

研究设计与关键结果

  • 研究类型为元研究及临床指南质量评价,系统检索2026年1月至4月Embase、PubMed、SciELO、Scopus、LILACS、Google Scholar及指南库,纳入4部含危重症成人营养风险筛查推荐的临床实践指南、共识声明和立场文件。
  • AGREE II评价总体方法学质量满意,范围与目的84.4%、表达清晰性92.0%,适用性最低为50.0%。
  • AGREE-REX评价总体推荐质量中等(64.8%),中国重症医学会指南得分最高(77.8%)。
  • 支持推荐意见的原始研究多被ROBINS-E评定为高或很高偏倚风险,一项系统评价被AMSTAR 2评定为极低置信度。

证据类型、等级与局限

  • 证据类型为元研究及临床指南质量评价,采用AGREE II、AGREE-REX、ROBINS-E和AMSTAR 2工具进行评价。
  • 局限:纳入指南在推荐可信度、适用性和证据质量方面存在重要局限;支持推荐意见的原始研究多为高或很高偏倚风险,一项系统评价为极低置信度。

对床旁实践的改变

  • 作者认为未来指南制定需更高质量的证据合成、透明的偏倚风险评估和改进的实施策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Clinical practice guidelines (CPGs) are essential tools to support evidence-based nutritional care in critically ill patients; however, the methodological quality and credibility of recommendations for nutritional risk screening remain unclear. This study aimed to evaluate the methodological quality of CPGs addressing nutritional risk screening in critically ill adults and to critically appraise the evidence supporting these recommendations. A systematic search was conducted between January and April 2026 in Embase, PubMed, SciELO, Scopus, LILACS, Google Scholar, and guideline repositories. CPGs, consensus statements, and position papers, including nutritional risk screening recommendations for critically ill adults were eligible. Guideline quality was assessed using the AGREE II and AGREE-REX instruments. Original studies and systematic reviews supporting nutritional risk screening recommendations were critically appraised using ROBINS-E and AMSTAR 2, respectively. Four CPGs were included. AGREE II assessment demonstrated satisfactory methodological quality overall, particularly in Scope and Purpose (84.4%) and Clarity of Presentation (92.0%), whereas Applicability showed the lowest performance (50.0%). AGREE-REX evaluation demonstrated moderate overall recommendation quality (64.8%), with the Chinese Society of Critical Care Medicine guideline presenting the highest score (77.8%). Most original studies supporting recommendations were classified as having high or very high risk of bias, and one systematic review was classified as critically low confidence. Although the included guidelines demonstrated satisfactory methodological quality, important limitations were identified regarding recommendation credibility, applicability, and evidence quality. These findings highlight the need for higher-quality evidence synthesis, transparent risk-of-bias assessment, and improved implementation strategies in future guideline development.

来源:J Hum Nutr Diet,查看原文。版权归原作者所有。

参考来源

  1. Reis AMD, Pinheiro MD, Hauschild DB, et al. Nutritional Risk Screening Recommendations for Critically Ill Patients: A Meta-Research Study and Quality Appraisal of Clinical Guidelines. J Hum Nutr Diet. 2026. PMID: 42494313. doi:10.1111/jhn.70321

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。